Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Morphological and Serological Criteria of Plaque Vulnerability: Risk Assessment for Symptomatic and Asymptomatic Carotid Artery Stenosis

NCT02124928 is registered in ClinicalTrials.gov with Prim PD Dr Afshin Assadian as lead sponsor.

NCT NCT02124928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02124928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Morphological and Serological Criteria of Plaque Vulnerability: Risk Assessment for Symptomatic and Asymptomatic Carotid Artery Stenosis
Lead sponsor
Prim PD Dr Afshin Assadian
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2012
Completion date
December 31, 2017
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, carotid artery disease